| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |